Stems Cells May Lower Infection Risk in Transplant Recipients Renal and Urology News The use of mesenchymal stem cells derived from bone marrow instead of antibody induction may result in a lower incidence of acute rejection in adults receiving related-donor kidney transplants. John Schieszer reports in today's Medical Minute that ... |
